Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Frontiers in Immunology
|
August 8, 2022
Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study
Beatriz Perdiguero, Benedikt Asbach, Carmen E Gómez, et al.
Journal of Virology
|
February 14, 2018
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates
Kevin O Saunders, Sampa Santra, Robert Parks, et al.
Journal of Virology
|
February 10, 2017
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates
Juan García-Arriaza, Beatriz Perdiguero, Jonathan L Heeney, et al.
Journal of Virology
|
October 17, 2019
Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC"
Karen V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.
Journal of Virology
|
November 16, 2018
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC
Karen V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.
Vaccine
|
September 13, 2011
Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)
Felipe García, Juan Carlos López Bernaldo de Quirós, Carmen E Gómez, et al.
Journal of Virology
|
June 5, 2015
Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates
Juan García-Arriaza, Beatriz Perdiguero, Jonathan Heeney, et al.
Emerging Microbes & Infections
|
August 1, 2024
Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium
Laura Marcos-Villar, Beatriz Perdiguero, María López-Bravo, et al.
Journal of Virology
|
November 16, 2018
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost
Benedikt Asbach, Karen V Kibler, Josef Köstler, et al.
Journal of Virology
|
April 10, 2015
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost
Sandrine L Hulot, Bette Korber, Elena E Giorgi, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Frontiers in Immunology
|
August 8, 2022
Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study
Beatriz Perdiguero, Benedikt Asbach, Carmen E Gómez, et al.
Journal of Virology
|
February 14, 2018
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates
Kevin O Saunders, Sampa Santra, Robert Parks, et al.
Journal of Virology
|
February 10, 2017
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates
Juan García-Arriaza, Beatriz Perdiguero, Jonathan L Heeney, et al.
Journal of Virology
|
October 17, 2019
Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC"
Karen V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.
Journal of Virology
|
November 16, 2018
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC
Karen V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.
Vaccine
|
September 13, 2011
Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)
Felipe García, Juan Carlos López Bernaldo de Quirós, Carmen E Gómez, et al.
Journal of Virology
|
June 5, 2015
Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates
Juan García-Arriaza, Beatriz Perdiguero, Jonathan Heeney, et al.
Emerging Microbes & Infections
|
August 1, 2024
Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium
Laura Marcos-Villar, Beatriz Perdiguero, María López-Bravo, et al.
Journal of Virology
|
November 16, 2018
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost
Benedikt Asbach, Karen V Kibler, Josef Köstler, et al.
Journal of Virology
|
April 10, 2015
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost
Sandrine L Hulot, Bette Korber, Elena E Giorgi, et al.
Page
of 7